Home › Anal Cancer › NCT05217940
Screening Women With Prior HPV for Anal Neoplasia
Recruiting
The Effectiveness of Screening Women With Lower Genital Tract Neoplasia or Cancers for Anal Cancer Precursors
Who can join
Ages 35 and older · Women
Full eligibility criteria
Inclusion Criteria: * Women with a history of pathologically proven high-grade genital HPV-associated neoplastic disease (cervical intraepithelial neoplasia 2+, vulvar intraepithelial neoplasia 2+, or vaginal intraepithelial neoplasia 2+, or history of non-metastatic cervical, vaginal or vulvar cancer) * Documented HIV seronegativity * Aged 35 years and older * Seen in the Mount Sinai Health System (MSHS) or the Harris Health System (HHS) in Houston * English or Spanish speaking Exclusion Criteria: • prior history or high resolution anoscopy
About the study
The goal of this single arm trial is to prospectively evaluate screening methods for anal cancer precursors in HIV uninfected women with a history of lower genital tract neoplasias and cancers.
What is being tested
- Diagnostic tests for anal cancer screening (diagnostic test)
Sponsor: Icahn School of Medicine at Mount Sinai · Participants: 300 · Started: Mar 2, 2022
Contact the study team
- Daniela Solis · Phone: 305-775-2140
Official record on ClinicalTrials.gov — NCT05217940
Locations in the U.S.
| New York | Icahn School of Medicine at Mount Sinai, New York |
| South Carolina | Medical University of South Carolina, Charleston |
| Texas | University of Texas M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.